The Recent IPO Market — 5 Deals to Watch

In This Article:

The IPO market may not be at the go-go levels of the late 1990s, but the environment is still fairly bullish. This is especially the case with technology companies and biotechs. Note that there have been ten deals that have posted returns of over 100%.

However, by August, the IPO market will essentially close down. This is normal, as many investors will be on vacation.

OK then, so for the next couple weeks, what are the interesting deals that will hit the market? Well, Let’s take a look at five:

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

IPOs to Watch: Bloom Energy

Bloom Energy, which was founded in 2002, is a high-profile Silicon Valley clean energy operator. The company has built a stationary power generation platform — that relies on natural gas or biogas — for the commercial and industrial (C&I) segments. A system can produce 250 kilowatts of power in half the size of a standard 30-foot shipping container. Customers include biggies like Home Depot (NYSE:HD), AT&T (NYSE:T) and Kaiser Permanente.

Despite all this, Bloom Energy will likely face lots of scrutiny from investors. Consider that the losses remain heavy. Last year, they came to $263 million — compared to $376 million in revenues! The company also has only $88 million in the bank and the debt load is $950.5 million.

There are also concerns about the political environment. After all, the Trump Administration is not exactly interested in clean energy.

As for the offering, Bloom energy plans to issue 18 million shares in the range of $13 to $15 per share (it is encouraging that insiders expect to purchase $50 million of the allocation). The company will list on the New York Stock Exchange under the ticker of BE and the lead underwriters include JP Morgan (NYSE:JPM), Morgan Stanley (NYSE:MS), Credit Suisse (NYSE:CS), KeyBanc Capital Markets and BofA Merrill Lynch (NYSE:BAC).

IPOs to Watch: Tilray

Tilray, which is based in Canada, is a cannabis producer. In fact, the company was one of the first to obtain a license from Health Canada.

And Tilray has wasted little time in capitalizing on the opportunity. The company already has established distribution in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand and South Africa. There is also a production facility that is certified for Good Manufacturing Practices (GMP), which is based on the requirements of the European Medicines Agency (EMA).

Now, the IPO will not be cheap. Consider that, at the mid-point of its range, the shares will still be expensive. But, then again, this probably won’t stop investors from piling in. The fact is that the cannabis market remains red-hot and Tilray will be a pure play on it.